» Authors » Yuzo Shimokawa

Yuzo Shimokawa

Explore the profile of Yuzo Shimokawa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 31
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ohno A, Fujimori N, Kaku T, Shimokawa Y, Miyagahara T, Suehiro Y, et al.
Dig Dis Sci . 2024 Sep; 70(1):419-428. PMID: 39342525
Background: Almost all previous reports on endoscopic ultrasound-guided hepaticogastrostomy (EUS-HGS) involve malignant distal bile duct strictures. However, the feasibility of EUS-HGS for malignant hilar biliary obstruction (MHBO) remains unclear. Aims:...
2.
Koga T, Ishida Y, Hashigo S, Shimokawa Y, Harima H, Okamoto K, et al.
Gastrointest Endosc . 2024 Sep; PMID: 39278283
Background And Aims: EUS-guided biliary drainage (EUS-BD) has shown promising procedural outcomes in high-volume centers. Although inferior procedural outcomes were reported in inexperienced centers during the early days of EUS-BD,...
3.
Shimokawa Y, Akiho H, Fujimori N
Endoscopy . 2024 Feb; 56(S 01):E153-E155. PMID: 38359887
No abstract available.
4.
Date K, Tatsuguchi T, Shimokawa Y, Niina Y, Kitahara D, Kuga H, et al.
Surg Case Rep . 2023 Jun; 9(1):102. PMID: 37306825
Background: Mixed neuroendocrine-non-neuroendocrine neoplasms of the ampulla of Vater are rare and heterogenous, making it difficult to achieve a definitive preoperative diagnosis. Herein, we describe a patient in whom a...
5.
Minaga K, Kitano M, Uenoyama Y, Hatamaru K, Shiomi H, Ikezawa K, et al.
Endosc Ultrasound . 2022 Dec; 11(6):478-486. PMID: 36537385
Background And Objectives: Although the use of a long metal stent is favored for EUS-guided hepaticogastrostomy (EUS-HGS) for the relief of malignant biliary obstruction (MBO), endoscopic reintervention (E-RI) at the...
6.
Miyagahara T, Fujimori N, Ueda K, Takamatsu Y, Matsumoto K, Teramatsu K, et al.
Asia Pac J Clin Oncol . 2022 Dec; 19(4):533-541. PMID: 36478079
Aim: Drug-induced interstitial lung disease (DI-ILD) is a serious adverse event during chemotherapy. This study aimed to obtain real-world data of the incidence, clinical characteristics, predictive factors, and prognosis of...
7.
Miki M, Fujimori N, Ueda K, Lee L, Murakami M, Takamatsu Y, et al.
J Clin Med . 2022 Sep; 11(17). PMID: 36079012
Although the combination of nanoliposomal irinotecan plus fluorouracil/folinic acid (nal-IRI/FF) exhibited survival benefits in gemcitabine-refractory patients with advanced pancreatic cancer (APC) in the phase III NAPOLI-1 trial, there is limited...
8.
Minaga K, Yamashita Y, Ogura T, Takenaka M, Shimokawa Y, Hisa T, et al.
Dig Endosc . 2018 Jul; 31(2):180-187. PMID: 30039611
Objectives: Percutaneous transhepatic gallbladder drainage (PTGBD) is widely used for patients with acute cholecystitis. There are little data on the efficacy and safety of endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) replacement...
9.
Yanai H, Yahara N, Furuya T, Hayashi H, Murakami T, Shimokawa Y, et al.
J Gastrointest Cancer . 2015 May; 47(1):107-10. PMID: 25972063
No abstract available.
10.
Ito T, Igarashi H, Niina Y, Hijioka M, Matsuo S, Shimokawa Y, et al.
JOP . 2010 Nov; 11(6):648-9. PMID: 21068507
No abstract available.